0000912282-23-000380.txt : 20230922 0000912282-23-000380.hdr.sgml : 20230922 20230922085501 ACCESSION NUMBER: 0000912282-23-000380 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230922 DATE AS OF CHANGE: 20230922 EFFECTIVENESS DATE: 20230922 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vesalius Cardiovascular Inc. CENTRAL INDEX KEY: 0001904804 IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-492772 FILM NUMBER: 231270319 BUSINESS ADDRESS: STREET 1: 210 WEST BROADWAY, UNIT 200 CITY: VANCOUVER STATE: A1 ZIP: V5Y 3W2 BUSINESS PHONE: (604) 559-6162 MAIL ADDRESS: STREET 1: 210 WEST BROADWAY, UNIT 200 CITY: VANCOUVER STATE: A1 ZIP: V5Y 3W2 D 1 primary_doc.xml X0708 D LIVE 0001904804 Vesalius Cardiovascular Inc. 210 West Broadway, Unit 200 VANCOUVER A1 BRITISH COLUMBIA, CANADA V5Y 3W2 (604) 559-6162 CANADA (FEDERAL LEVEL) None None Corporation true Peter Skarsgard 210 West Broadway, Unit 200 Vancouver A1 BRITISH COLUMBIA, CANADA V5Y 3W2 Director Executive Officer Vincent Ledoux 210 West Broadway, Unit 200 Vancouver A1 BRITISH COLUMBIA, CANADA V5Y 3W2 Director Executive Officer Other Technology Decline to Disclose 06b false 2023-09-18 true true true true Unit offering, each unit consisting of 1 common share and 1 warrant? each warrant may be exercised for 1 common share at CND$6.00 prior to August 29, 2025 false 0 98836 37821 61015 Total remaining to be sold represents 13,650 warrants issued to US Investors, exercisable at CAD$6.00 until August 29, 2025. Does not include securities offered or sold under Reg S. Canadian dollars converted to USD at exchange rate of 1.3426. false 2 0 0 0 Vesalius Cardiovascular Inc. /s/ Vincent Ledoux Vincent Ledoux COO 2023-09-21